Indiana Orthopaedic Hospital
Indianapolis, Indiana, 46278, United States
NCT Number: NCT00940446
The purpose of this study is to compare the use of INSORB absorbable staples with metal staples on surgical incision healing after total hip replacement. The study evaluates wound healing, complications, and patient satisfaction regarding wound comfort and appearance after surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Indianapolis, Indiana, 46278, United States
Subcuticular closure of wounds can provide superior results to percutaneous suture closure due to the elimination of suture or staple tracts. These tracts can lead to infection and migration of epithelial cells adding to scarring, and cross-hatching scars which remain after healing. Absorbable staples can provide a rapid, secure, subcuticular closure of skin as an alternative to the traditional, manual staple or suture closure. This study will compare INSORB absorbable staples to externally applied standard metal staples with respect to effectiveness of incision closure, acute healing, subject comfort level, security and appearance after total hip replacement.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
absorbable staples required for wound closure
Other names: Insorb absorbable stapler, GDW
wound closure with metal staples
Other names: Ethicon metal stapler
Time frame: Discharge from initial hospital stay (2-5 days post-op)
Incisional drainage, swelling, gaps of incision. Drainage and swelling will be objectively determined by investigator. Gaps will be measured in millimeters.
Time frame: up to 6 weeks post-op
Assessment of wound for complications, especially hematomas at 6 weeks post surgery. Participants will be scored based on presence of a hematoma or not.
Orthopaedic Research Foundation
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01976637
Erythema, Neurologic Manifestations
View Trial DetailsNCT01301677
Erythema, Neurologic Manifestations
Gräfelfing, Bavaria, Germany
View Trial DetailsNCT07725900
Dry Skin, Erythema
Semarang, Central Java, Indonesia
View Trial DetailsNCT07479004
Dermatitis, Dermatitis, Contact
Banská Bystrica, Slovakia
View Trial Details